Chen Ruofei Trophy, Pearson Vincent, Suebkinorn Orathai, Bulto Lemma N, Pincha Baduge Mihirika, Anderson Alice, Nelson Adam J, Zoungas Sophia, Clark Robyn A, Nicholls Stephen J
Monash Victorian Heart Institute, Monash University, Victoria, Australia.
JBI, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia, Australia.
Eur J Prev Cardiol. 2024 Nov 4. doi: 10.1093/eurjpc/zwae362.
Cardiovascular disease (CVD) remains a significant public health concern, influenced by both genetic susceptibility and lifestyle factors. Integrating genetic risk information into clinical practice shows promise but has yielded mixed results regarding its impact on CVD prevention and management. This systematic review aimed to assess the impact of providing genetic CVD risk information on health behaviours, psychological outcomes, and risk factors.
Following JBI methodology and PRISMA 2020 guidelines, four electronic databases and two trial registries were searched for randomised controlled trials evaluating the impact of genetic risk information on the CVD risk profile. Data was synthesised using a narrative synthesis approach.
Of the 3,596 articles retrieved, 11 studies were eligible. Genetic risk information showed modest improvements in dietary behaviour but had inconclusive effects on physical activity and medication adherence. Minimal changes in psychological outcomes were noted, including a slight decrease in depression. The impact on traditional risk factors, such as systolic blood pressure and total cholesterol was also limited. Bias across all studies was noted.
Genetic CVD risk information has limited effects on clinical outcomes and psychological factors, despite its potential to encourage some health behaviour changes. These findings suggest that genetic risk information alone may not be sufficient to significantly reduce cardiovascular risk, highlighting the need for further research to better understand its long-term effects.
心血管疾病(CVD)仍然是一个重大的公共卫生问题,受遗传易感性和生活方式因素的影响。将遗传风险信息整合到临床实践中显示出一定前景,但在其对心血管疾病预防和管理的影响方面,结果不一。本系统评价旨在评估提供遗传性心血管疾病风险信息对健康行为、心理结果和风险因素的影响。
遵循循证卫生保健国际中心(JBI)方法和2020年系统评价和Meta分析首选报告项目(PRISMA)指南,检索了四个电子数据库和两个试验注册库,以查找评估遗传风险信息对心血管疾病风险状况影响的随机对照试验。采用叙述性综合方法对数据进行综合分析。
在检索到的3596篇文章中,有11项研究符合条件。遗传风险信息显示饮食行为有适度改善,但对身体活动和药物依从性的影响尚无定论。心理结果方面变化甚微,包括抑郁略有减轻。对传统风险因素,如收缩压和总胆固醇的影响也有限。注意到所有研究中均存在偏倚。
遗传性心血管疾病风险信息对临床结果和心理因素的影响有限,尽管它有可能鼓励一些健康行为的改变。这些发现表明,仅遗传风险信息可能不足以显著降低心血管风险,这凸显了需要进一步研究以更好地了解其长期影响。